#JPM26: Sandoz CEO on Ozempic generic launch plans for 2026news2026-01-16T14:42:01+00:00January 16th, 2026|Endpoints News|
New York sues ex-Emergent CEO over insider trading during vaccine manufacturing strugglenews2026-01-15T20:36:02+00:00January 15th, 2026|Endpoints News|
Trump asks Congress to codify ‘most favored nation’ dealsnews2026-01-15T19:10:11+00:00January 15th, 2026|Endpoints News|
FDA to meet Novo Nordisk on troubled site; AbbVie buys drug-device factory news2026-01-15T13:52:56+00:00January 15th, 2026|Endpoints News|
Manufacturers benefit as pharma customers invest back in USnews2026-01-14T20:19:22+00:00January 14th, 2026|Endpoints News|
Thermo Fisher to lay off 421 workers as it winds down lab product site in North Carolinanews2026-01-14T15:59:10+00:00January 14th, 2026|Endpoints News|
AbbVie reaches MFN deal with the White House, pledges billions to US manufacturingnews2026-01-13T14:53:42+00:00January 13th, 2026|Endpoints News|
FDA shares eased manufacturing rules for cell and gene therapiesnews2026-01-12T18:04:55+00:00January 12th, 2026|Endpoints News|
Novartis to build fourth US radiotherapy factory in Florida news2026-01-09T16:36:40+00:00January 9th, 2026|Endpoints News|
J&J strikes drug pricing, tariff deal with the White Housenews2026-01-09T14:17:44+00:00January 9th, 2026|Endpoints News|
